🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Tumor Pancreas

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer NCT06478225NA1 site📍 Shanghai RenJi Hospital · Tests: BGT007H Cell Injection In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers NCT07206355n/a1 site📍 Nottingham University of Nottingham Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer NCT07600268Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Stereotactic Body Radiotherapy (SBRT) with maintenance therapy, Maintenance therapy Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients NCT05929885Phase 21 site📍 Singapore National Cancer Centre, Singapore · Tests: Low Dose OXIRI (LD-OXIRI) Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source NCT02843945Phase 1, Phase 26 sites📍 Tampa📍 Chicago📍 Oak Lawn CivaTech Oncology · Tests: Directional Brachytherapy Source Implant Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial NCT07787156NA1 site📍 Boston Brigham and Women's Hospital · Tests: Telephone education session, Online educational materials A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors NCT05740956Phase 11 site📍 Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10502 A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer NCT07238283Phase 31 site📍 Beijing Jiangsu HengRui Medicine Co., Ltd. · Tests: Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate, nab-paclitaxel; gemcita… Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours NCT06345079Phase 217 sites📍 Sydney📍 Wollongong📍 Brisbane Australasian Gastro-Intestinal Trials Group · Tests: Cessation of somatostatin analogues, Continuation of somatostatin analogues TCR1188-ABC Cells in KRAS-mutated Cancers NCT07594067Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: TCR1188-ABC cells, Fludarabine + Cyclophosphamide combination, Tocilizumab A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites📍 Duarte📍 La Jolla📍 Loma Linda Pierre Fabre Medicament · Tests: tabelecleucel Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. NCT06840067NA1 site📍 Wuwei Gansu Wuwei Tumor Hospital · Tests: carbon ion radiotherapy (CIRT) A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer NCT07895498Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Minocycline, Hypochlorous Acid, Hydrocortison cream, Triamcinolone (TAC) 0.1% cream, Clobetasol Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors NCT06819215Phase 1, Phase 21 site📍 Jinan Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Tests: VB15010 Role of Genetic Factors in the Development of Lung Disease NCT00001532n/a2 sites📍 Bethesda📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study NCT06852014NA1 site📍 Málaga Fundación Pública Andaluza para la Investigación de Málaga … · Tests: Dietary Supplement: Experimental Treatment with nutritional suplement A + nutritional suplement B, Dietary Supplement: … 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916Phase 1, Phase 25 sites📍 Duarte📍 Orange📍 Stanford Lantheus Medical Imaging · Tests: 64Cu-LNTH-1363S Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy NCT07823049Phase 348 sites📍 Shanghai📍 Beijing📍 Beijing Evopoint Biosciences Inc. · Tests: XNW28012 for injection, XNW28012 Mimetic for Injection A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors NCT07429851n/a1 site📍 Milan European Institute of Oncology Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX NCT07044453Phase 2, Phase 31 site📍 Rouen University Hospital, Rouen · Tests: Gem/Nabpaclitaxel infusion, mFOLFIRINOX infusion Institut Paoli-Calmettes Pancreatic Neoplasms Database NCT02869581n/a1 site📍 Marseille Institut Paoli-Calmettes · Tests: Data collection Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer NCT06454383Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Cholestyramine, Computed Tomography, Diagnostic Imaging, Gemcitabine AI-Powered Precision Decision-Making for Pancreatic Diseases NCT07439757n/a1 site📍 Shanghai Changhai Hospital · Tests: Diagnosis by Artificial Intelligence model Energy Expenditure and Nutrition After Pancreatic Surgery NCT07703813n/a1 site📍 Athens Evangelismos Hospital · Tests: Pancreatectomy, Indirect calorimetry Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients NCT06046794NA1 site📍 Marseille Institut Paoli-Calmettes · Tests: Analyze of GemCore status Holistic Acupuncture for Patients With Chemotherapy Induced Nausea NCT07201194NA1 site📍 Vejle Vejle Hospital · Tests: Holistic acupuncture and acupressure, Standard medical treatment Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer NCT05462496Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Biopsy, FOLFIRINOX, Ciprofloxacin, Metronidazole, Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy